These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12238732)

  • 1. Developing profiles of postmenopausal women being prescribed estrogen therapy to prevent osteoporosis.
    Amonkar MM; Mody R
    J Community Health; 2002 Oct; 27(5):335-50. PubMed ID: 12238732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does estrogen adequately protect postmenopausal women against osteoporosis: an iconoclastic perspective.
    Orwoll ES; Nelson HD
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1872-4. PubMed ID: 10372678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of pharmacotherapy and counseling for osteoporosis management in visits to US ambulatory care physicians by women.
    Lee E; Zuckerman IH; Weiss SR
    Arch Intern Med; 2002 Nov; 162(20):2362-6. PubMed ID: 12418951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis: new hope for the future.
    Masi L; Bilezikian JP
    Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of postmenopausal estrogen therapy on bone density in elderly women.
    Felson DT; Zhang Y; Hannan MT; Kiel DP; Wilson PW; Anderson JJ
    N Engl J Med; 1993 Oct; 329(16):1141-6. PubMed ID: 8377776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gerontologic aspects of postmenopausal measurement of bone density and prevention of osteoporosis].
    Wenderlein JM; Eissfeldt K; Heber F; Dannert E
    Geburtshilfe Frauenheilkd; 1995 Nov; 55(11):647-52. PubMed ID: 8707043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen therapy for postmenopausal symptoms and prevention of osteoporosis.
    Sagraves R
    J Clin Pharmacol; 1995 Sep; 35(9S):2S-10S. PubMed ID: 8530714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
    Levine JP
    Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing osteoporosis in symptomatic postmenopausal women.
    Gallagher JC; Levine JP
    Menopause; 2011 Jan; 18(1):109-18. PubMed ID: 20661164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis and fractures in postmenopausal women using estrogen.
    Nelson HD; Rizzo J; Harris E; Cauley J; Ensrud K; Bauer DC; Orwoll E;
    Arch Intern Med; 2002 Nov; 162(20):2278-84. PubMed ID: 12418942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.
    Hosking D; Chilvers CE; Christiansen C; Ravn P; Wasnich R; Ross P; McClung M; Balske A; Thompson D; Daley M; Yates AJ
    N Engl J Med; 1998 Feb; 338(8):485-92. PubMed ID: 9443925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Not all postmenopausal women on chronic steroid and estrogen treatment are osteoporotic: predictors of bone mineral density.
    Thompson JM; Modin GW; Arnaud CD; Lane NE
    Calcif Tissue Int; 1997 Nov; 61(5):377-81. PubMed ID: 9351878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of osteoporosis among Jewish and Arab women aged 45-74 in Israel: national women's health interview survey.
    Nitzan-Kaluski D; Chinich A; Ifrah A; Merom D; Green MS
    J Gend Specif Med; 2003; 6(1):17-23. PubMed ID: 12661173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician counseling on hormone replacement therapy and bone loss: do socioeconomic and racial characteristics of women influence counseling?
    Neuner JM; McCarthy EP; Davis RB; Phillips RS
    J Womens Health (Larchmt); 2003 Jun; 12(5):495-504. PubMed ID: 12869297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 Jun; 5(6):513-54. PubMed ID: 10147266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
    Gallagher JC; Fowler SE; Detter JR; Sherman SS
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG
    CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription attitudes among gynecologists towards two particular risk factors of osteoporosis: the patient's age and her bone mineral density.
    Rozenberg S; Lefever A; Kroll M; Vandromme J; Paesmans M; Ham H
    Maturitas; 1999 May; 32(1):19-24. PubMed ID: 10423712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.